Canada · Delayed Price · Currency is CAD Medical Facilities Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 7.8% year-over-year to $63.1 million, with income from operations up 9.4% and EBITDA rising 7.1%. Strong cash position and significant share repurchases highlight ongoing capital returns, while active recruitment aims to address volume declines in certain segments.
-
Facility service revenue grew 10.8% year-over-year to $67.1 million, with income from operations up 17.6% and EBITDA up 13.8%. Sale of Oklahoma Spine Hospital boosted cash to $86.3 million, supporting ongoing capital returns and strategic focus.
Fiscal Year 2025
-
Q4 and full-year results showed strong revenue and earnings growth, supported by higher case volumes and operational efficiency. Major asset sales and share repurchases returned significant capital to shareholders, while the company remains debt-free and continues to monitor regulatory and competitive risks.
-
Income from operations and EBITDA grew strongly, driven by higher facility service revenue and improved case mix. Share repurchases reduced the outstanding share count by 20% year-to-date, while the company maintained a strong cash position and no corporate debt.
-
Second quarter results were impacted by lower volumes at Sioux Falls due to a clinic relocation, but other hospitals saw improved profitability. $52.2 million was returned to shareholders, and a new $40 million credit facility was secured. Operations at Sioux Falls are expected to normalize in the second half.
-
First quarter revenue and EBITDA were stable year-over-year, with higher surgical volumes offsetting one less surgical day. Significant capital was returned to shareholders, and the company maintains a strong cash position with no corporate debt.
Fiscal Year 2024
-
Strong 2024 results included higher income from operations and adjusted EBITDA, driven by the sale of a major asset and robust capital returns to shareholders. Q4 saw a slight revenue dip due to lower surgical volumes, but liquidity and balance sheet strength improved significantly.
-
Q3 revenue rose 11.2% to $115M, driven by $11.4M in PPP loan forgiveness, while operating income and EBITDA grew 11.7% and 8.3% year-over-year. Capital returns to shareholders and debt reduction continued.
-
Hospitals achieved higher surgical and pain management volumes, boosting revenue and EBITDA year-over-year. Black Hills expanded into heart and vascular care, while $6.9 million in PPP loans were forgiven post-quarter. Capital was returned to shareholders and debt reduced.